Topline data were announced from a phase 3 trial evaluating orforglipron, an oral GLP-1 receptor agonist, in adults with obesity or overweight and T2D.

Those living in regions with greater reimbursement for insulin pumps, continuous glucose monitors, glucometers, and insulin ...

You can’t turn on the TV without seeing ads for glucose-lowering GLP-1 drugs like Ozempic and Wegovy. A1C numbers are ...

Time-in-range (TIR) readings from a continuous glucose monitor (CGM) complemented A1c readings and provided a more complete picture of glucose control in patients with type 2 diabetes taking basal ...

Dear Dr. Roach: I am a 71-year-old male with Type 2 diabetes. My last A1C test showed a value of 7.8%. I have been taking Mounjaro weekly, which lowered my weight by about 20 pounds and my A1C level ...

For the first time, nonprofit Vitalant is offering blood donors an extra check on their health while they help save and ...

Diabetes is more common than you might think. More than 37 million people are living with diabetes in the United States—or 1 in 10 people, according to the CDC. The vast majority of those people have ...

Patients with diabetes receiving insulin treatment with lower cost sharing for blood glucose testing strips were more likely to achieve glycemic control than those with higher cost sharing. Objectives ...

During a joint symposium on Saturday, held as part of the 80th American Diabetes Association Scientific Sessions and hosted by JDRF President and CEO Aaron Kowalski, PhD, experts debated the merits ...

A blood drive was held at Chico State on Tuesday. It marks the beginning of a long series of drives across the Northstate, ...

If you miss out on the opportunity in August, you'll have another chance to get free A1C testing in November from the Red ...